Note to our followers: Due to a lack of sufficient funding, will cease daily publication of new content at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. If you wish to donate, your gift might help keep the site available to the public for a few more years, by defraying costs of web hosting and maintenance. All of our 6,000+ published articles contain lessons to help people improve their critical thinking about health care. Read more about our change in status. And here's how to make a donation.

Tag: Avastin


The limitations of progression-free survival as an endpoint – NPR addresses


Emotion, anecdotes, politics and ugliness in Avastin aftermath


Clash between data and emotion in FDA decision on Avastin for metastatic breast cancer